罕见病的基因检测
Genetic Testing for Rare Diseases.
作者信息
Millán José M, García-García Gema
机构信息
Instituto de Investigación Sanitaria La Fe, Molecular, Cellular and Genomics Biomedicine, 46026 Valencia, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), 28029 Madrid, Spain.
出版信息
Diagnostics (Basel). 2022 Mar 25;12(4):809. doi: 10.3390/diagnostics12040809.
Abstract
The term rare disease was coined in the 1970s to refer to diseases that have a low prevalence [...].
摘要
“罕见病”一词于20世纪70年代被创造出来，用以指代那些患病率较低的疾病[……]
相似文献
1
Genetic Testing for Rare Diseases.罕见病的基因检测
Diagnostics (Basel). 2022 Mar 25;12(4):809. doi: 10.3390/diagnostics12040809.
2
Special Issue: Rare Respiratory Diseases: A Personal and Public Health Issue.特刊：罕见呼吸道疾病：个人与公共卫生问题。
J Clin Med. 2021 Dec 16;10(24):5906. doi: 10.3390/jcm10245906.
3
Genomics of rare genetic diseases-experiences from India.罕见遗传病的基因组学：来自印度的经验。
Hum Genomics. 2019 Sep 25;14(1):52. doi: 10.1186/s40246-019-0215-5.
4
Issues in genetic testing for ultra-rare diseases: background and introduction.
Genet Med. 2008 May;10(5):309-13. doi: 10.1097/GIM.0b013e3181729d99.
5
The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.在罕见眼病中广泛开展基因组检测的必要性：ERN-EYE 立场声明。
Orphanet J Rare Dis. 2021 Mar 20;16(1):142. doi: 10.1186/s13023-021-01756-x.
6
Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects.罕见病的基因检测：伦理方面的系统评价
Front Genet. 2022 Jan 26;12:701988. doi: 10.3389/fgene.2021.701988. eCollection 2021.
7
An isthmus of isolation: The likely elevated prevalence of genetic disease in ancient Panama and implications for considering rare diseases in paleopathology.一个隔离地带：古代巴拿马地区可能较高的遗传疾病患病率及其对古病理学中罕见疾病研究的启示
Int J Paleopathol. 2021 Jun;33:1-12. doi: 10.1016/j.ijpp.2021.01.002. Epub 2021 Feb 10.
8
[THE DISEASE OF JOB].
Harefuah. 2019 Sep;158(9):612-614.
9
Optimal therapy for rare disorders and genetic diseases: ethical and political challenges.罕见疾病和遗传疾病的最佳治疗方法：伦理和政治挑战。
Proc West Pharmacol Soc. 2007;50:21-3.
10
Recent trend of increase in proportion of low birthweight infants in Japan.
Int J Epidemiol. 2001 Dec;30(6):1269-71. doi: 10.1093/ije/30.6.1269.
引用本文的文献
1
Perception of Social and Educational Quality of Life of Minors Diagnosed with Rare Diseases: A Systematic Review and Meta-Analysis.未成年人罕见病社会和教育生活质量感知的系统评价和荟萃分析。
Int J Environ Res Public Health. 2023 Jan 4;20(2):933. doi: 10.3390/ijerph20020933.
本文引用的文献
1
Precision medicine for rare diseases: The times they are A-Changin'.罕见病的精准医学：时代正在改变。
Curr Opin Pharmacol. 2022 Apr;63:102201. doi: 10.1016/j.coph.2022.102201. Epub 2022 Mar 4.
2
Identification of the First Single Exon 8 Structural Variants Associated with Autosomal Dominant Hearing Loss.首个与常染色体显性遗传性听力损失相关的第8外显子单结构变异的鉴定。
Diagnostics (Basel). 2022 Jan 15;12(1):207. doi: 10.3390/diagnostics12010207.
3
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.脊髓性肌萎缩症的治疗进展：对肌肉萎缩症和神经退行性疾病的展望
Neurol Res Pract. 2022 Jan 4;4(1):2. doi: 10.1186/s42466-021-00162-9.
4
Different Rates of the -Related Hearing Loss in Two Indigenous Peoples of Southern Siberia (Russia).俄罗斯西伯利亚南部两个原住民群体中与-相关听力损失的不同发生率。
Diagnostics (Basel). 2021 Dec 17;11(12):2378. doi: 10.3390/diagnostics11122378.
5
Current Status of Genetic Counselling for Rare Diseases in Spain.西班牙罕见病遗传咨询的现状
Diagnostics (Basel). 2021 Dec 9;11(12):2320. doi: 10.3390/diagnostics11122320.
6
When Familial Hearing Loss Means Genetic Heterogeneity: A Model Case Report.当家族性听力损失意味着基因异质性时：一个典型病例报告
Diagnostics (Basel). 2021 Sep 7;11(9):1636. doi: 10.3390/diagnostics11091636.
7
An Atypical Case of Head Tremor and Extensive White Matter in an Adult Female Caused by 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency.一例由3-羟基-3-甲基戊二酰辅酶A裂解酶缺乏症引起的成年女性头部震颤和广泛白质病变的非典型病例。
Diagnostics (Basel). 2021 Aug 28;11(9):1561. doi: 10.3390/diagnostics11091561.
8
Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome.波兰普拉德-威利综合征患者的基因型与围产期、诊断时间以及重组人生长激素治疗开始前人体测量数据的相关性
Diagnostics (Basel). 2021 Apr 28;11(5):798. doi: 10.3390/diagnostics11050798.
9
Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders.神经肌肉疾病基因检测的促进因素与障碍
Diagnostics (Basel). 2021 Apr 14;11(4):701. doi: 10.3390/diagnostics11040701.
10
Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel.溶酶体疾病的新一代分子研究：综合靶向检测板的临床整合
Diagnostics (Basel). 2021 Feb 12;11(2):294. doi: 10.3390/diagnostics11020294.
Zotero 插件